De-implementing Inhaled Steroids to Improve Care and Safety in COPD

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

181 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-09-06

Study Completion Date

2021-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This Quality Enhancement Research Initiative (QuERI) project is designed to determine efficacy and acceptance of an intervention method to provide primary care providers with patient-tailored electronic consults and corresponding unsigned orders for de-implementation of inhaled corticosteroids (ICS) for patients with COPD when ICS are not indicated by guidelines.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Air Pollution and Inhaled Corticosteroids in COPD

NCT06552364

COPD

NOT_YET_RECRUITING PHASE4

Comprehensive Patient-Centered Home-based Care Coaching for COPD Self-management

NCT06634810

Chronic Obstructive Pulmonary Disease

RECRUITING NA

The Effect of Inhaled Nitric Oxide on Deadspace in COPD

NCT04069052

Chronic Obstructive Pulmonary Disease

COMPLETED EARLY_PHASE1

An Educational Intervention to Improve Disease Management Knowledge of Hospitalized Patients With COPD

NCT03323190

Chronic Obstructive Pulmonary Disease Patient Education Inpatients

WITHDRAWN NA

Intermittent Intrapulmonary Deflation and Dyspnea Following Exercise in People With Chronic Obstructive Pulmonary Disease

NCT06956742

Chronic Obstructive Pulmonary Disease (COPD)

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Chronic obstructive pulmonary disease (COPD) is among the most common medical diagnoses among Veterans. Approximately half of those who carry a diagnosis of COPD are prescribed inhaled corticosteroids (ICS), despite ICS having no role among those patients without fixed airflow obstruction (AFO) and a limited role among those who do. Guidelines explicitly state that ICS for COPD patients should be limited to those with severe AFO and those with frequent exacerbations. Even this benefit comes at a cost, as ICS use has been shown in multiple randomized controlled trials to increase rates of pneumonia. After prolonged exposure, ICS is also associated with higher bone fracture risk, incidence of cataracts and poor diabetes control. Among patients without disease or with mild-moderate AFO and low risk of exacerbation, ICS have no demonstrated efficacy, but retain the risk of harm. For this reason, evidence-based guidelines specifically recommend against their use in mild-moderate AFO.

The goal of this project is to improve the delivery and safety of care by de-implementing the ineffective use of ICS among Veterans with a diagnosis of COPD who otherwise lack a clinical indication for the medication. The primary aim is to reduce ICS use among Veterans with limited clinical indication for the medication. Investigators will test an intervention to de-implement unnecessary use of inhaled corticosteroids in Veterans with chronic obstructive pulmonary disease (COPD) by having pulmonologists assume more responsibility for supporting COPD patients. The investigators will compare a substitution approach using proactive patient-tailored electronic consult (E-consult) compared to usual care with a single-session education outreach, which represents a non-intensive unlearning approach. The investigators are targeting the intervention to Patient Aligned Care Team (PACT) providers who are randomized to either receive the intervention or not receive the intervention. For patients within intervention PACTs, the project clinicians will leverage the VA's integrated healthcare informatics system using specialist support through proactive patient-tailored electronic consults (E-consult) and inputting unsigned orders on behalf of Primary Care Providers (PCPs) to recommend and facilitate de-implementation of ICS. Primary care providers will have final say in accepting (signing), modifying, or declining the recommendations.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Treatment of Chronic Obstructive Pulmonary Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Proactive patient-tailored electronic consult (E-consult)

Primary care clinicians receive patient-tailored guideline concordant treatment recommendations, including orders and rationale to discontinue inhaled corticosteroids.

Group Type OTHER

Guideline treatment recommendations

Intervention Type OTHER

Patient-tailored E-consult, orders and rationale to discontinue inhaled corticosteroids and discontinue or receive other COPD related care.

Usual care

Standard practice (usual care). Primary care providers treat their patients as usual.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Guideline treatment recommendations

Patient-tailored E-consult, orders and rationale to discontinue inhaled corticosteroids and discontinue or receive other COPD related care.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Provider:

Primary care provider (medical doctor/osteopathic physician, nurse practitioner, physician assistant \[MD/DO, NP, PA\]) assigned to a PACT from VA Puget Sound Health Care System or Edith Nourse Rogers Memorial Veterans Hospital (Bedford VA).

Patient:

* Patient is a Veteran who is assigned a VA PCP and has received Rx for an inhaled corticosteroid within the past 180 days.
* Patient has an inpatient or outpatient diagnosis of COPD in the prior two years.
* Patient has undergone spirometry in the past 5 years that indicates either no airflow obstruction or mild to moderate airflow obstruction indicated by a forced expiratory volume 1 (FEV1)/\[greater of forced vital capacity (FVC) or vital capacity (VC)\] =\< 0.7 \& FEV1% predicted \>= 30%.

Exclusion Criteria

Patients:

* Very severe airflow obstruction (\<30% FEV1 % predicted)
* Severe disease as indicated by 1 inpatient COPD exacerbation in the year prior
* Severe disease as indicated by 2 outpatient COPD exacerbations in the year prior
* International Classification of Diseases (ICD) 9 and/or 10 diagnosed or clinically indicated asthmatics
* Significant bronchodilator response on spirometry (\>12% increase in FEV1 post bronchodilator; \>375 mL post-bronchodilator improvement)

Eligible Sex

ALL

Accepts Healthy Volunteers

No